Founded in
2020
Creating a New Class of Drugs to Address Incurable Autoimmune DiseasesEntelexo is creating modern treatments for immune-mediated diseases, such as psoriasis, using novel engineered exosome technology.
ACTIVE FOUNDERS
Founder 1
MILAD RIAZIFAR,
Dr. Riazifar has worked on stem cells over a decade and on exosomes a subclass of stem cell derived extracellular vesicles since 2012. During his Ph.D studies at the Stem Cell Research Center at the University of California Irvine, he pioneered a cell-free exosome-based approach to treat Multiple Sclerosis. At City of Hope, he was part of a clinical translation team initiating the world’s first clinical trial using stem cell exosomes for the treatment of type I diabetes.
Twitter: | Linkedin: https://www.linkedin.com/in/miladriazifar/
Founder 2
Todd Schurr,
Multidisciplinary engineer with diverse experience in cellular biology, electrical engineering, automotive, and more. To quote Einstein, I am "passionately curious" about just about everything.
Twitter: | Linkedin: https://www.linkedin.com/in/todd-schurr/
Founder 3
Cameron Taylor,
MSE in Biomedical Engineering from University of Michigan, Class of 2018 Co-Founder and CTO at Entelexo Biotherapeutics.
Twitter: | Linkedin: https://www.linkedin.com/in/cameron-taylor-448b5a130/
Founder 4
,
Twitter: | Linkedin:
Founder 5
,
Twitter: | Linkedin:
Founder 6
,
Twitter: | Linkedin:
Irvine
2020
3
Monday
By Appointments
Tuesday
N/A
Wednesday
N/A
Thursday
N/A
Friday
N/A
Saturday
N/A
Sunday
N/A
29 January 2023 8:55 local time
Add a review